Murrell DF, Bodemer C, Bruckner AL, Cunningham T, Davis C, Fern?ndez MF, Kiritsi D, Maher L, Sprecher E, Torres-Pradilla M, Kern JS. Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study. Br J Dermatol. 2025 May 19; 192(6):1007-1017.

Cooper JT, Svoboda E, Prochazka AV, Ha DM. Effects of cognitive-behavioral therapy for insomnia compared with controls among cancer survivors: a systematic review and meta-analysis of randomized trials. BMC Cancer. 2025 May 14; 25(1):871.

Goel V, Kaizer A, Darrow D, Rosielle D, Owens B, Blaes A. Cancer patients quality of life after intrathecal drug delivery for advanced pain management: a patient-reported outcome analysis. Pain Med. 2025 May 01; 26(5):261-268.

Lin Z, Rifas-Shiman SL, Perng W, Capotosto MP, Shifren JL, Joffe H, Hivert MF, Chavarro JE, Oken E, Aris IM. Neighborhood Vulnerability and Age of Natural Menopause and Menopausal Symptoms Among Midlife Women. JAMA Netw Open. 2025 May 01; 8(5):e2512075.

Chalmers JD, Burgel PR, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2025 Apr 24; 392(16):1569-1581.

Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou JK. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).

Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, Rasouli N, Sourij H, Videmark A, Verma S. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet. 2025 05 03; 405(10489):1580-1593.

Pfuhl G, Prazeres F, Kowal M, Aavik T, Abad-Villaverde B, Afhami R, Aguilar L, Akello G, Al-Shawaf L, Antfolk J, Atama CS, Duyar DA, Baiocco R, Balim S, Batres C, Belkacem Y, Besson T, Bode A, Boga M, Boudesseul J, Boussena M, Brahim H, Burduli N, Can AR, Cetinkaya H, Chirumbolo A, Chubinidze D, Cornec C, Dinic BM, Dural S, Duyar I, Ebimgbo SO, Etchezahar E, Fedor P, Frackowiak T, Frederick DA, Galasinska K, Garc?a FE, Yepes TG, Grigoryev D, Guemaz F, Hromatko I, Ikizer G, Janssen SMJ, Kamburidis JA, Kavcic T, Kervyn N, Khan F, Kobylarek A, Koyuncu M, Kunisato Y, Lacko D, Landa-Blanco M, Lidborg LH, Lins S, Mandzyk T, Mari S, Marot TA, Martinez-Banfi M, Mattiassi ADA, Mayorga-Lascano M, Mebarak M, Mesk? N, Miccoli MR, Mikuliciute V, Milfont TL, Mi?etic K, Morelli M, Natividade JC, Ndukaihe ILG, Novaes F, Omar SS, Fauzee MSO, Otterbring T, ?zener B, Ozer S, Park JH, Banai IP, Pazhoohi F, Perun M, P?rko M, Pirtskhalava E, Pisanski K, Plohl N, Ponnet K, Prokop P, Ribeiro MFF, Ros?rio F, Sahin A, Sahli FZ, ?akan D, Senyk O, Siepelmeyer H, Ribeiro da Silva D, Singh S, Solak ?, S?ylemez S, Studzinska A, Tan CS, Topanova GT, Bulut MT, Toplu-Demirtas E, Tr?moli?re B, Tulyakul S, Ungaretti J, Valentova JV, Varella MAC, Vintila M, Volkodav T, Wlodarczyk A, Yeh YY, Yoo G, Zerhouni O, Zum?rraga-Espinosa M, Zupancic M, Sorokowski P. A preliminary study on the role of personal history of infectious and parasitic diseases on self-reported health across countries. Public Health. 2025 May; 242:220-227.

Powles T, Choueiri TK, Albiges L, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, G?m?s M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Rizzo M, Shinde R, Saretsky TL, He L, Perini RF, Vickery D, Rini B. Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial. Lancet Oncol. 2025 Apr; 26(4):491-502.

Silverberg JI, Anderson P, Cappelleri JC, Piercy J, Levenberg ME, Myers DE, Gerber RA. Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States. Arch Dermatol Res. 2025 Mar 12; 317(1):556.